Multiple allergic reactions, but no known trigger? Your immune genes may be the answer.

HLA-DQ2 is part of your immune system’s presentation machinery. Its job is to take fragments of proteins from food, bacteria, and environmental substances and display them to your T-cells, essentially showing your immune system what’s entering your body. This is a critical gate-keeping function. The T-cells then decide whether to mount an immune response or tolerate the substance.

Carrying HLA-DQ2, present in roughly 25-30% of people of European ancestry, fundamentally changes how your immune system categorizes certain proteins. HLA-DQ2 essentially programs your immune system to view harmless substances as threats and mount an aggressive response against them. This isn’t just about celiac disease (which requires HLA-DQ2 plus gluten exposure plus additional genetic and environmental factors). It also predisposes you to broader immune dysregulation where your T-cells attack a wider range of antigens.

In your daily life, this manifests as unpredictable reactions. Your immune system is essentially misinterpreting signals. A protein in a food you’ve eaten a hundred times suddenly triggers a cascade. Environmental proteins that other people tolerate without a second thought send your system into overdrive. Because HLA-DQ2 controls the fundamental recognition step, reactions driven by this gene tend to be broad and multiple.

Interleukin-13 is a chemical messenger that your immune system releases during allergic and parasitic responses. Its job is to shift your immune system toward a Th2 response (the allergic immune response) and, in the airway and lungs, to trigger mucus production and airway smoothing muscle contraction. In normal amounts, this is protective. In excess, it becomes the engine of allergic inflammation.

Carriers of IL13 variants, present in roughly 30-35% of the population, have a genetic predisposition to produce higher amounts of this inflammatory signal. When you encounter an allergen, your IL13 system overresponds, triggering excessive mucus, airway narrowing, and persistent inflammation even after the trigger is gone. Because IL13 is so central to the Th2 allergic pathway, variants here tend to produce reactions that are exaggerated and longer-lasting.

You experience this as reactions that linger. You’re exposed to something, and hours or even days later you’re still congested, still itchy, still reacting. Your airways feel tight. Your sinuses feel inflamed. Your gut feels sensitive. Because IL13 signals affect both airway and gut tissue, you may have allergy symptoms across multiple body systems simultaneously.

Interleukin-4 is the master signal for IgE production. Your immune system uses IL4 to tell B-cells to make allergic antibodies (IgE). In normal amounts, this protects against parasites and helps coordinate allergic responses. But when IL4 signaling is overactive, your immune system cranks up IgE production to supraphysiological levels, making your mast cells hypersensitive to tiny amounts of allergen.

The IL4 -590C>T variant, carried by roughly 30% of the population, increases IL4 production and shifts your immune system toward Th2 dominance. This means your B-cells are constantly being told to make more IgE, priming your mast cells for overreaction at lower and lower allergen thresholds. Your baseline allergic reactivity is essentially turned up from the factory.

You notice this as hypersensitivity that doesn’t match the exposure. A tiny amount of pollen triggers a severe reaction. A single dust particle causes itching. Cross-reactivity becomes common, where you’re allergic to things that share similar proteins with your original triggers. Your reactions feel out of proportion to the provocation.

Toll-like receptor 4 (TLR4) is your immune system’s bacterial sensor. When bacteria or their lipopolysaccharide (LPS) components enter your system, TLR4 recognizes them and triggers an innate immune response. This is your first line of defense against infection. TLR4 activation also primes your adaptive immune system for more refined responses. Under normal circumstances, this system is protective.

The TLR4 D299G variant, present in roughly 10% of people of European ancestry, reduces your immune system’s ability to recognize bacterial LPS, impairing your early warning system and potentially allowing abnormal bacterial signals to slip past your immune detection. This doesn’t just affect bacterial responses. A hypofunctional TLR4 correlates with increased allergic reactivity because your immune system’s baseline alert status shifts. Without proper bacterial sensing, your immune system compensates by becoming more reactive to other threats.

In practice, you may notice that your allergic reactions feel worse after certain exposures (changed water source, travel, antibiotic use, dietary changes). You may also have a history of recurrent infections mixed with allergic symptoms. Because TLR4 is involved in both bacterial sensing and allergic immune balance, dysfunction here creates a complicated picture where infections and allergies seem linked.

FUT2 (secretor status gene) encodes an enzyme that determines whether you secrete ABO blood group antigens into your mucous membranes, saliva, and digestive fluids. This seems like a minor detail, but it has massive consequences for your microbiome composition and intestinal immune development. The ABO antigens in your secretions act as a food source for specific beneficial bacteria. If you’re a secretor (FUT2 functional), your mucous membranes actively feed bacteria like Akkermansia and Faecalibacterium. If you’re a non-secretor (FUT2 variant), those bacteria are starved and your microbiome shifts toward less beneficial species.

Non-secretor status, present in roughly 20% of European ancestry populations, fundamentally alters your gut bacteria composition, reducing beneficial species and allowing pathogenic bacteria to proliferate, which directly increases intestinal permeability and allergic immune priming. Your gut barrier becomes more permeable. Bacterial lipopolysaccharides (LPS) leak into your bloodstream at higher rates, triggering low-grade endotoxemia. Your gut-associated lymphoid tissue (GALT) is constantly primed by abnormal bacterial signals.

You experience this as allergic reactions that feel triggered by gut health. Certain foods worsen your reactions. Your digestion feels off. You may have IBS-like symptoms mixed with your allergies. Travel, antibiotics, and dietary changes seem to trigger flares. Because your gut barrier function is compromised at the genetic level, nothing you eat will fully compensate without addressing the underlying microbiome composition.

The vitamin D receptor (VDR) is a critical regulator of immune tolerance. When vitamin D binds to VDR in your immune cells, it activates a cascade that increases regulatory T-cells (Tregs) and dampens inflammatory responses. VDR also controls expression of tight junction proteins in your gut barrier and helps calibrate your innate immune response. A properly functioning VDR system is what allows your immune system to distinguish between real threats and harmless substances.

VDR variants, particularly the f allele (FokI polymorphism), affect the length and transcriptional efficiency of the VDR protein. People carrying the longer f allele or certain tag SNPs have reduced VDR responsiveness to vitamin D, meaning that even adequate serum vitamin D levels don’t fully activate immune tolerance pathways. Your immune system remains in a more reactive state because the molecular signal to calm down isn’t getting through efficiently.

You experience this as broad allergic reactivity that intensifies seasonally or with sun exposure changes. Winter months tend to be worse. Your reactions feel like your immune system never gets the signal to stand down. You may be supplementing vitamin D already, but higher doses don’t seem to help proportionally. This is because your VDR isn’t receiving the signal efficiently, even when vitamin D levels are adequate.